The global cell freezing media market was valued at USD 1.17 billion in 2024 and is projected to reach USD 2.37 billion by 2033, registering a CAGR of 8.58% from 2025 to 2033. This growth is driven by the increasing adoption of commercial cell freezing media as a reliable alternative to in-house preparations, along with the advantages of ready-to-use cryopreservation formulations over conventional freezing techniques. Additionally, rising demand for effective freezing media across a broad spectrum of end-users and the introduction of innovative products by key market players are expected to further support market expansion.A significant contributor to market growth is the rapid expansion of biobanking activities worldwide. Biobanks play a crucial role in storing and preserving biological specimens—including human cells, tissues, and biofluids—for biomedical research, diagnostics, and therapeutic development. As genomic research, disease modeling, and biomarker discovery advance, there is an increased need for high-quality, viable samples that require robust cryopreservation solutions to maintain long-term stability and functionality. The growing emphasis on personalized and precision medicine further strengthens this demand, as researchers require diverse, well-preserved samples to analyze genetic variations and develop tailored therapies. To meet these evolving needs, biobanks are increasingly adopting serum-free, xeno-free, and regulatory-compliant freezing media, particularly for samples intended for clinical use.
Key Market Trends & Insights
North America accounted for the largest share of the global market at 38.19% in 2024.
The U.S. cell freezing media industry is expected to experience significant growth throughout the forecast period.
By product, the DMSO segment dominated with a 70.87% share in 2024.
By application, the stem cells segment held the largest share at 28.99% in 2024.
By end use, pharmaceutical and biotechnology companies led the market with a 40.20% share in 2024.
Download a free sample PDF of the Cell Freezing Media Market Intelligence Study by Grand View Research.
Market Size & Forecast
2024 Market Size: USD 1.17 Billion
2033 Projected Market Size: USD 2.37 Billion
CAGR (2025–2033): 8.58%
Largest Market (2024): North America
Fastest-Growing Region: Asia Pacific
Competitive Landscape
The market is dominated by established players with extensive product portfolios, strong technological capabilities, and global distribution networks. Leading companies such as Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., and BioLife Solutions, Inc. leverage their expertise in the life sciences sector to develop high-quality, GMP-compliant, serum-free, and xeno-free cryopreservation media tailored for both research and clinical use.
Other key players—including HiMedia Laboratories, Bio-Techne, PromoCell GmbH, Capricorn Scientific, Vitrolife AB, AMSBIO, and ZENOGEN PHARMA CO., LTD.—are strengthening their market presence by offering specialized formulations designed for sensitive cell types such as stem cells, immune cells, and reproductive cells. Many of these companies are also integrating their products with automated freezing systems to enhance scalability, process consistency, and post-thaw cell viability.